市场调查报告书
商品编码
1190736
内窥镜后处理市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)Endoscope Reprocessing Market - Growth, Trends, Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内,内窥镜后处理市场预计将以 7.8% 的复合年增长率增长。
COVID-19 对内窥镜后处理市场产生了重大影响,原因是大流行早期严格的封锁规定导致后处理设施突然关闭。 此外,大流行早期内窥镜检查的减少对市场增长产生了显着影响。 然而,在大流行后采取适当措施保护内窥镜后处理程序有望推动市场增长。 例如,2021 年 10 月发表的一篇 NCBI 论文指出,鼓励内窥镜后处理人员继续使用适当的个人防护装备,如手套、防护服和麵罩。 此类内窥镜安全再处理指南有望在预测期内推动市场增长。
推动内窥镜后处理市场增长的主要因素是:与内窥镜相关的传染病病例不断增加,医院对内窥镜设备的投资增加,以及需要内窥镜手术的疾病。 已经证实,内窥镜仪器在疾病诊断和治疗中的使用正在增加。 肺癌和慢性阻塞性肺病等呼吸系统疾病负担的增加正在推动预测期内的市场增长。 例如,根据 2022 年 3 月发表的 NCBI 论文,估计 2021 年南亚国家慢性阻塞性肺病的合併患病率为 11.1%。 它还指出,印度北部 (19.4%) 和孟加拉国 (13.5%) 的慢性阻塞性肺病患病率最高。 如此高的慢性阻塞性肺疾病负担有望推动内窥镜检查的需求,从而促进市场增长。
此外,由于内窥镜被广泛用于癌症诊断,癌症患者数量的增加也有望促进对内窥镜的后处理需求,从而促进市场的增长。 例如,IARC 2021 报告称,这些人中有 115 万人患有结直肠癌,预计到 2040 年这一数字将达到 192 万。 此外,2021 年 7 月发表的一篇 NCBI 论文提到,印度结直肠癌的年龄标准化发病率为每 10 万人中男性 7.2 例,女性 5.1 例。 因此,内窥镜主要用于诊断目的的各种类型癌症的负担迅速增加,从长远来看正在推动内窥镜后处理的增长。
此外,对恢復更快、术后感染更少、疼痛更小、疤痕更少、出血控制更好、精度更高的手术的需求不断增长,导致对各种内窥镜器械的需求预计会增加。 市场上的主要参与者都在关注新产品的批准,以扩大他们的产品组合。 例如,2021 年 4 月,Advanced Sterilization Products 的 ASP AEROFLEX 自动内窥镜清洗机获得了美国食品药品监督管理局的认可。 因此,内窥镜清洗机市场的单位数量正在增加,预计将导致市场高速增长。
但是,执行内窥镜手术的熟练专业人员的短缺以及对再处理器械安全性的担忧预计会阻碍市场增长。
内窥镜清洗机将可重复使用的内窥镜的外表面和内通道暴露在高浓度消毒剂或液体化学灭菌剂中,以去除内窥镜内部或表面的污染物。一种旨在杀死微生物的设备。 此外,建议使用自动内窥镜清洗机的各种指南也有望促进所研究领域的增长。 例如,2021年1月,一次性内窥镜文章指南中提到,在正常情况下,一个週期的高水平消毒,最好是自动内窥镜清洗机,可以确保充分的清洗。列出了GI Society的更新指南。
同样,考虑到自动内窥镜洗消机的额外功能,预计产品发布和批准的增加将在预测期内推动研究领域。 同样,2022 年 6 月,Getinge 推出了更新的 ED-Flow 自动内窥镜清洗机。 ED-Flow 可有效地对柔性内窥镜进行洩漏测试、清洁和高水平消毒,提供有效和可靠的结果。 此外,还增加了一个新的过程指示灯,即使在房间的另一端也可以轻鬆检查过程状态,从而改善了部门的工作流程并提高了生产率。 因此,此类创新产品的推出将提高效率并推动市场增长。
此外,2021 年 5 月,美国食品和药物管理局 (FDA) 批准了 Advanced Sterilization 的 ASP Aeroflex,它可以自动清洁和消毒内窥镜,并获得 510(k) 许可。 Advanced Sterilization 的设备可以在 22 分钟内自动清洁和消毒来自多个製造商的柔性内窥镜,无需手动试纸测量消毒剂浓度。 因此,此类批准可能会增加细分市场的增长。
北美占据大部分市场份额,美国在北美地区占据主要份额。 该地区疾病数量的增加以及主要市场参与者不断增加的发布和收购是推动所研究市场增长的主要因素。 该地区癌症病例的增加也有望推动对内窥镜检查程序的需求,从而刺激市场增长。
例如,根据加拿大癌症协会的数据,2022 年将有约 24,300 名加拿大人被诊断出患有结直肠癌。 因此,结直肠癌的增加将需要更高的诊断率,这将推动对内窥镜检查的需求,从而提高监测市场的增长率。
此外,该地区产品发布的增加和主要参与者的高度集中预计将提振市场。 例如,2021年1月,奥林巴斯推出了带内窥镜收纳柜的ScopeLocker,HEPA铰链门内窥镜收纳系统。 奥林巴斯感染预防产品阵容的扩大响应了胃肠道领域瞬息万变的环境。 2021年1月,IDESCO将发布内窥镜干燥存储“IDESCO ENDO D3”。 因此,上述所有因素预计将在预测期内增加北美市场的增长。
由于后处理过程中使用的设备和消耗品数量众多,该市场既有跨国公司,也有本地公司。 一些市场参与者包括 Advanced Sterilization Products(强生公司)、Cantel Medical、Custom Ultrasonics、Ecolab Inc、Endo-Technik W. Griesat、Getinge AB、Metrex Research, LLC、Olympus Corporation、STERIS plc。
The endoscope reprocessing market is poised to grow at a CAGR of 7.8% during the forecasted period.
COVID-19 had significantly affected the endoscope reprocessing market owing to the abrupt shutdown of reprocessing facilities in the initial days of the pandemic due to the strict lockdown regulations. Also, the reductions in endoscopy procedures during the initial stages of the pandemic had a notable impact on the growth of the market. However, the adoption of the appropriate measure to follow the endoscope reprocessing procedures during the post-pandemic period is expected to drive the growth of the market. For instance, the NCBI article published in October 2021, mentioned that endoscope reprocessing staff should continue to adopt appropriate personal protective equipment including gloves, gowns, face shields, and other equipment are recommended. Such guidelines for the safe reprocessing of endoscopes are expected to drive the growth of the market over the forecast period.
The major factors driving the growth of the endoscope reprocessing market include the rising cases of endoscopy-related infections, growing hospital investments in endoscopy instruments, and the rising number of diseases that require endoscopy procedures. Increased usage of endoscopic devices has been observed in disease diagnosis and treatment. The growing burden of respiratory diseases, such as lung cancer, and chronic obstructive pulmonary disorders is propelling the market's growth over the forecast period. For instance, according to the NCBI article published in March 2022, the estimated pooled prevalence of COPD was 11.1% in South Asian countries in 2021. The report also mentioned that the prevalence of COPD was highest in North India (19.4%) and Bangladesh (13.5%). Such a high burden of Chronic Obstructive Pulmonary Disease is expected to drive the demand for endoscopy procedures, thereby contributing to the growth of the market.
Additionally, the rising number of cancer cases is also expected to contribute to the demand for endoscopy reprocessing as endoscopy procedures are widely used in diagnosing cancer, thereby contributing to the market's growth. For instance, IARC 2021 reported that out of these cases, 1.15 million cases are of colon cancer, which is expected to reach 1.92 million by 2040. Also, the NCBI article published in July 2021, mentioned that the age-standardized incidence rates of colorectal cancer in India were 7.2 and 5.1 per 100,000 population for men and women. Such a rapidly rising burden of different types of cancers, in which endoscopes are largely used for diagnostic purposes, is boosting the growth of endoscope reprocessing over time.
Furthermore, rising demand for surgeries with faster recovery, fewer post-surgery infections, less pain, reduced scarring, better control of bleeding, and increased accuracy are anticipated to boost the demand for various endoscopy devices. Major players in the market are focusing on the approval of new products to expand their product portfolio. For instance, in April 2021, Advanced Sterilization Products received United States Food and Drug Administration's support for the ASP AEROFLEX Automatic Endoscope Reprocessor. Thus, the rising number of endoscopy reprocessing devices in the market will likely lead to high growth of the market.
However, the dearth of skilled professionals to carry out endoscopic procedures and the concerns regarding the safety of reprocessed instruments are the factors expected to hinder the market growth.
Automated endoscope reprocessors are designed to kill microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to high-level disinfectant or liquid chemical sterilant solutions. Also, the suggested usage of automated endoscope reprocessors in various guidelines is expected to contribute to the growth of the studied segment. For instance, in January 2021, the Single Use Endoscopy article guidelines enlisted the GI societies' updated guidelines which mentioned that under normal circumstances, one cycle of high-level disinfection, preferably in an automated endoscope reprocessor is enough to ensure adequate reprocessing.
Likewise, the increasing product launches and approvals, given the added features of automated endoscope reprocessors, are expected to drive the studied segment over the forecast period. Similarly, in June 2022, Getinge launched an updated version of the ED-Flow automated endoscope reprocessors. ED-Flow efficiently performs leak testing, cleaning, and high-level disinfection of flexible endoscopes, delivering effective, reliable results. New process indicator lights have been added to allow easy visibility of the process status from across the room, which creates improved department workflow leading to higher productivity. Hence, such innovative product launches would improve efficiency and will fuel market growth.
Additionally, in May 2021, United States Food and Drug Administration (FDA) granted 510(k) clearance for Advanced Sterilization's ASP Aeroflex, a device that automatically cleans and sterilizes endoscopes. The Advanced Sterilization device can automatically clean and disinfect flexible endoscopes from multiple manufacturers in 22 minutes, eliminating the need to use manual test strips to measure the disinfectant's concentration. Hence, such approvals are likely to increase segment growth.
North America holds the majority of the share and in the North American region, United States holds the major share. The rising number of disorders and the increasing launches and acquisitions by key market players in the region are the major drivers for the growth of the studied market. Increasing cases of cancer in this region are also expected to drive the demand for endoscopy procedures, thereby fueling the growth of the market.
For instance, according to the Canadian cancer society data 2022, nearly 24,300 Canadians will be diagnosed with colorectal cancer in 2022. Thus, increasing colorectal cancer would require a higher diagnostic rate, which will fuel the demand for endoscopy and hence will increase the growth rate of the studied market.
Additionally, the increasing number of product launches and high concentration of major players in the region is expected to boost the market. For instance, in January 2021, Olympus launched the endoscope storage cabinet, the ScopeLocker with HEPA-hinged door endoscope storage system. This line expansion of Olympus' infection prevention offering addresses a rapidly shifting environment in the gastrointestinal field. Also, in January 2021, IDESCO launched the endoscope drying storage cabinet called the IDESCO ENDO D3. Hence, all the above-mentioned factors are expected to augment the growth of the North American market over the forecast period.
The market studied involves both multinational and local companies owing to a large number of devices and consumables being used in the reprocessing process. Some of the market players are Advanced Sterilization Products (Johnson & Johnson Company), Cantel Medical, Custom Ultrasonics, Ecolab Inc, Endo-Technik W. Griesat, Getinge AB, Metrex Research, LLC., Olympus Corporation, STERIS plc., and Wassenburg Medical (A Member of Hoya).